Management of Septal Infarction
The management of septal infarction requires immediate reperfusion therapy via primary percutaneous coronary intervention (PCI) within 90 minutes of first medical contact, along with standard post-MI care including dual antiplatelet therapy, beta-blockers, ACE inhibitors, and statins. 1
Initial Assessment and Management
Immediate Evaluation:
- Obtain 12-lead ECG within 10 minutes of first medical contact
- Establish IV access
- Monitor cardiac rhythm with defibrillation capability
- Administer oxygen only if saturation is <90%
Reperfusion Strategy:
- Primary PCI is the first-line treatment when available within 90 minutes
- If PCI is not available within 90 minutes, consider fibrinolysis
- Administer loading doses of:
- Aspirin (75-325 mg)
- P2Y12 inhibitor (ticagrelor 180 mg or prasugrel 60 mg)
- Anticoagulation with unfractionated heparin (70-100 U/kg IV)
Pain Management:
- Intravenous opioids (4-8 mg morphine) with additional 2 mg doses at 5-minute intervals as needed
- Avoid NSAIDs due to prothrombotic effects 2
Specific Management for Septal Complications
Ventricular Septal Rupture (VSR)
VSR is a serious complication occurring in 1-2% of MI cases, with mortality of 54% within the first week and 92% within the first year without surgery 2, 3.
Diagnosis:
- New systolic murmur (may be soft or absent)
- Echocardiography with color Doppler to identify location and size of defect
- Hemodynamic deterioration
Management:
- Urgent cardiac surgical repair is indicated for patients with VSR 2
- Intra-aortic balloon counterpulsation for hemodynamic support while awaiting surgery 2
- Pharmacological support with vasodilators (IV nitroglycerin) if no cardiogenic shock 2
- Invasive monitoring with judicious use of inotropes and vasodilators 2
- CABG should be performed at the same time as VSR repair 2
Timing of Surgery:
- For large VSR with cardiogenic shock, immediate surgery offers the only chance of survival 2
- Even without hemodynamic instability, early surgery is usually indicated as the defect may increase in size 2
- Risk factors for poor surgical outcomes include: cardiogenic shock, posterior location, right ventricular dysfunction, age, and delayed surgery 2, 4
Right Ventricular Infarction with Septal Involvement
Management principles 2:
- Early reperfusion should be achieved if possible
- AV synchrony should be maintained and bradycardia corrected
- Optimize RV preload (volume challenge if JVP normal/low)
- Optimize RV afterload (treat concomitant LV dysfunction)
- Use inotropic support for hemodynamic instability not responsive to volume challenge
- Consider delaying CABG for 4 weeks if significant RV dysfunction is present
Post-MI Care
Pharmacological Therapy:
- Beta-blockers: Start early IV therapy followed by oral therapy if no contraindications 2
- ACE inhibitors: Begin within 24 hours for anterior STEMI or if EF ≤0.40 1
- Dual antiplatelet therapy for 12 months 1
- High-intensity statin therapy 1
- Aldosterone antagonist for patients with EF ≤0.40 and symptomatic heart failure or diabetes 1
Monitoring for Complications:
Long-term Management:
Special Considerations for Septal Infarction
- Septal infarction may lead to conduction abnormalities including AV block requiring temporary or permanent pacing 5
- Loss of septal Q waves may be seen on ECG 6
- Careful monitoring of hemodynamics is essential as unpredictable deterioration can develop rapidly 3
- Color flow Doppler, two-dimensional, and transesophageal echocardiography are preferred for rapid diagnosis of septal complications 3
Prognosis
The prognosis depends on:
- Extent of septal damage
- Presence of complications (especially VSR)
- Timing of intervention
- Pre-existing cardiac function
- Associated coronary artery disease
For patients with VSR, early surgical intervention significantly improves outcomes, with hospital mortality between 25-60% after surgery, and 95% of survivors achieving NYHA class I or II functional status 2.